Viral Vector Platforms – Accelerating Timelines To Manufacturing & Commercialization
Time: 1:00 pm
day: Day One
Details:
• Besides usual challenges such as specificity of delivery, control of activity, and immunogenicity, gene therapy developers encounter hurdles associated with manufacturing and scale-up, product analysis, and limited skilled workforce
• FUJIFILM Diosynth Biotechnologies provides a flexible viral vector development and manufacturing platform
• This presentation will focus on strategic considerations that can help our partners navigate these challenges by streamlining the critical path from pre-clinical and clinical development through commercialization